Mayne Pharma has officially opened its new $80 million, oral solid-dose commercial manufacturing facility in Greenville, NC. Custom-designed from the ground up and under construction for two years, Mayne Pharma’s new 126,000 sq. ft. facility leverages best-in-class containment design to meet or exceed the quality and safety standards of major drug regulatory authorities. The new facility more than quadruples the company’s capacity to manufacture oral solid-dose pharmaceutical p...